Results
104
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
104 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
3022 | CN¥13.73 | -4.0% | -44.6% | CN¥18.3b | n/a | PE52.3x | E29.9% | 0.6% | Materials | ||
2755 | CN¥9.43 | -4.9% | 10.4% | CN¥9.1b | CN¥13.00 | PS5.6x | E90.7% | 0% | Pharmaceuticals & Biotech | ||
688513 | CN¥33.62 | -3.9% | -9.8% | CN¥5.9b | CN¥51.02 | PE24.4x | E22.0% | 1.2% | Pharmaceuticals & Biotech | ||
688687 | CN¥24.23 | -5.4% | -19.0% | CN¥4.1b | CN¥39.66 | PE34.5x | E29.6% | 1.0% | Pharmaceuticals & Biotech | ||
300896 | CN¥170.55 | -0.7% | -48.4% | CN¥51.3b | CN¥317.42 | PE26x | E25.2% | 1.9% | Pharmaceuticals & Biotech | ||
605555 | CN¥17.81 | -8.0% | -1.1% | CN¥6.7b | CN¥26.95 | PE18.2x | E21.1% | 2.0% | Consumer Durables | ||
300496 | CN¥44.82 | -3.6% | -57.2% | CN¥21.0b | CN¥60.76 | PE53x | E24.7% | 0.6% | Software | ||
300218 | CN¥13.88 | -9.1% | 48.4% | CN¥3.1b | CN¥19.24 | PE23.5x | E31.2% | 0.9% | Consumer Durables | ||
300143 | CN¥7.90 | 6.2% | -30.9% | CN¥5.0b | CN¥10.12 | PE57.5x | E28.5% | 0% | Healthcare | ||
300354 | CN¥31.51 | -0.5% | -29.8% | CN¥4.3b | CN¥47.04 | PE41.6x | E37.3% | 0.4% | Tech | ||
600977 | CN¥10.97 | 0.3% | -22.4% | CN¥20.3b | CN¥11.60 | PE114.9x | E44.9% | 0.6% | Media | ||
2230 | CN¥42.06 | -6.0% | -35.0% | CN¥98.2b | CN¥52.45 | PE232.6x | E28.3% | 0.2% | Software | ||
688776 | CN¥54.22 | -2.1% | -39.7% | CN¥5.9b | n/a | PE59.5x | E70.5% | 0.4% | Capital Goods | ||
603197 | CN¥30.78 | -6.5% | -45.5% | CN¥6.5b | CN¥60.09 | PE18.5x | E30.1% | 2.1% | Automobiles | ||
600588 | CN¥9.66 | -6.2% | -52.2% | CN¥35.1b | CN¥15.47 | PS3.3x | E51.5% | 0% | Software | ||
300705 | CN¥26.06 | -5.2% | 40.0% | CN¥12.7b | CN¥35.16 | PE30.4x | E27.2% | 0.9% | Pharmaceuticals & Biotech | ||
300348 | CN¥7.36 | 2.5% | -29.7% | CN¥5.8b | CN¥10.03 | PE158x | E33.8% | 0.1% | Software | ||
688389 | CN¥15.99 | -4.0% | -33.5% | CN¥6.9b | CN¥23.87 | PE19.7x | E22.5% | 1.8% | Healthcare | ||
688050 | CN¥69.96 | -9.3% | -39.3% | CN¥13.4b | CN¥119.17 | PE40.4x | E27.2% | 0.4% | Healthcare | ||
301093 | CN¥18.79 | -7.3% | -44.9% | CN¥2.5b | CN¥28.82 | PE25.3x | E33.9% | 3.2% | Healthcare | ||
688319 | CN¥8.88 | -7.9% | -60.1% | CN¥3.5b | n/a | PS7.2x | E66.5% | 0.4% | Pharmaceuticals & Biotech | ||
601127 | CN¥88.45 | 2.7% | 101.9% | CN¥135.5b | CN¥123.05 | PS2.3x | E43.9% | 0% | Automobiles | ||
688111 | CN¥198.15 | -20.7% | -56.7% | CN¥91.6b | CN¥338.78 | PE64.6x | E21.9% | 0.4% | Software | ||
300034 | CN¥15.37 | -0.5% | -39.9% | CN¥12.2b | CN¥23.58 | PE33.7x | E26.5% | 0.8% | Capital Goods |